IS3790A7 - Hliðstæð aðferð til framleiðslu á 3-[-2-(dímeltýlamínó)etýl]-N-metýl-1H-indól-5-metansúlfónamíð súlfat salti - Google Patents

Hliðstæð aðferð til framleiðslu á 3-[-2-(dímeltýlamínó)etýl]-N-metýl-1H-indól-5-metansúlfónamíð súlfat salti

Info

Publication number: IS3790A7
Authority: IS; Iceland
Prior art keywords: indole; dimethylamino; ethyl; methyl; preparation
Prior art date: 1990-12-12

Application number

IS3790A

Other languages

English (en)

Other versions

IS1706B (is

Inventor

Craig Joanne

Leslie Crookes Derek

John Skittrall Stephen

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-12

Filing date

1991-12-11

Publication date

1992-06-13

1991-12-11 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

1992-06-13 Publication of IS3790A7 publication Critical patent/IS3790A7/is

1998-12-10 Publication of IS1706B publication Critical patent/IS1706B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Indole Compounds (AREA)

IS3790A 1990-12-12 1991-12-11 Hliðstæð aðferð til framleiðslu á 3-[-2-(dímeltýlamínó)etýl]-N-metýl-1H-indól-5-metansúlfónamíð súlfat salti IS1706B (is)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909026998A GB9026998D0 (en)	1990-12-12	1990-12-12	Medicaments

Publications (2)

Publication Number	Publication Date
IS3790A7 true IS3790A7 (is)	1992-06-13
IS1706B IS1706B (is)	1998-12-10

Family

ID=10686904

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS3790A IS1706B (is)	1990-12-12	1991-12-11	Hliðstæð aðferð til framleiðslu á 3-[-2-(dímeltýlamínó)etýl]-N-metýl-1H-indól-5-metansúlfónamíð súlfat salti

Country Status (36)

Country	Link
US (2)	US5554639A (is)
EP (1)	EP0490689B1 (is)
JP (1)	JP2994037B2 (is)
KR (1)	KR100211479B1 (is)
CN (2)	CN1030890C (is)
AP (1)	AP230A (is)
AT (1)	ATE119881T1 (is)
AU (1)	AU650706B2 (is)
BE (1)	BE1005085A3 (is)
CA (1)	CA2098302C (is)
CH (1)	CH684192A5 (is)
CY (1)	CY2005A (is)
CZ (1)	CZ281931B6 (is)
DE (1)	DE69108200T2 (is)
DK (1)	DK0490689T3 (is)
EG (1)	EG20219A (is)
ES (1)	ES2069836T3 (is)
FR (1)	FR2670487B1 (is)
GB (2)	GB9026998D0 (is)
GR (1)	GR3015430T3 (is)
HK (1)	HK82697A (is)
HU (1)	HU211937A9 (is)
IE (1)	IE62894B1 (is)
IL (1)	IL100330A (is)
IS (1)	IS1706B (is)
IT (1)	IT1252868B (is)
MX (1)	MX9102501A (is)
MY (1)	MY109265A (is)
NL (1)	NL9102071A (is)
NZ (1)	NZ240942A (is)
PT (1)	PT99757B (is)
RU (1)	RU2108328C1 (is)
TW (2)	TW300886B (is)
WO (1)	WO1992010477A1 (is)
YU (1)	YU48926B (is)
ZA (1)	ZA919750B (is)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ282060B6 (cs) *	1992-06-05	1997-05-14	Merck Sharp And Dohme Limited	Sulfátová sůl substituovaného triazolu, způsob její výroby, farmaceutický prostředek s jejím obsahem a způsob jeho výroby
FR2749846B1 (fr) *	1996-06-17	1998-09-11	Pf Medicament	Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique
US8022095B2 (en) *	1996-08-16	2011-09-20	Pozen, Inc.	Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6106837A (en) *	1997-05-15	2000-08-22	Hirsch; Alan R.	Method of treating headaches, and article of manufacture therefor
US6066092A (en) *	1997-11-06	2000-05-23	Cady; Roger K.	Preemptive prophylaxis of migraine device and method
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
US6132757A (en)	1998-05-01	2000-10-17	Neal R. Cutler	Treatment of sexual dysfunction in certain patient groups
US6426084B1 (en)	2000-06-19	2002-07-30	Neal R. Cutler	Treatment of sexual dysfunction in certain patient groups
US6187790B1 (en)	1999-03-04	2001-02-13	Neal R. Cutler	Use of cilostazol for treatment of sexual dysfunction
GB9926250D0 (en) *	1999-11-06	2000-01-12	Knoll Ag	Chemical process
US6610271B2 (en) *	2000-05-10	2003-08-26	University Of Kentucky Research Foundation	System and method for intranasal administration of lorazepam
US20040115133A1 (en) *	2000-05-10	2004-06-17	Wermeling Daniel P.	Intranasal opioid compositions
US6451813B1 (en)	2001-01-26	2002-09-17	R. T. Alamo Ventures I, Llc	Treatment of gastroparesis in certain patient groups
US6562838B2 (en) *	2001-01-26	2003-05-13	R. T. Alamo Ventures I, L.L.C.	Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) *	2001-01-26	2002-10-01	R.T. Alamo Venturesi, Llc	Methods for the treatment of central nervous system disorders in certain patient groups
US20040176359A1 (en) *	2001-02-20	2004-09-09	University Of Kentucky Research Foundation	Intranasal Benzodiazepine compositions
US20030096748A1 (en) *	2001-06-04	2003-05-22	The Regents Of The University Of Michigan	Methods and compositions for the treatment of diseases associated with signal transduction aberrations
ATE404193T1 (de) *	2001-06-05	2008-08-15	Ronald Aung-Din	Topische migränetherapie
US8329734B2 (en) *	2009-07-27	2012-12-11	Afgin Pharma Llc	Topical therapy for migraine
US7041677B2 (en) *	2002-03-01	2006-05-09	R.T. Alamo Ventures I, Llc	Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) *	2002-05-13	2007-04-24	Kansas State University Research Foundation	Compositions and methods for the treatment of hepatitis C virus infection
US7074893B2 (en) *	2002-06-03	2006-07-11	Regents Of The University Of Michigan	Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US20040068000A1 (en) *	2002-10-02	2004-04-08	Mintong Guo	Compression coated tablets
EP1575566B1 (en) *	2002-12-26	2012-02-22	Pozen, Inc.	Multilayer dosage forms containing naproxen and triptans
US20080213363A1 (en) *	2003-01-23	2008-09-04	Singh Nikhilesh N	Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
WO2004076403A1 (en) *	2003-02-24	2004-09-10	Transform Pharmaceuticals, Inc.	Sumatriptan crystalline forms, pharmaceutical compositions and methods
CA2529528A1 (en) *	2003-06-20	2004-12-29	Ronald Aung-Din	Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
US20050089558A1 (en) *	2003-10-28	2005-04-28	Alamo Pharmaceuticals, Llc	Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
US20050269402A1 (en) *	2004-06-03	2005-12-08	Tyfone, Inc.	System and method for securing financial transactions
CA2569964A1 (en) *	2004-06-10	2005-12-29	Duramed Pharmaceuticals, Inc.	Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
MY147767A (en)	2004-06-16	2013-01-31	Janssen Pharmaceutica Nv	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
BRPI0610864A2 (pt)	2005-05-20	2010-08-03	Janssen Pharmaceutica Nv	processo para preparação de derivados de sulfamida
WO2007070504A2 (en) *	2005-12-13	2007-06-21	Morton Grove Pharmaceuticals, Inc.	Stable and palatable oral liquid sumatriptan compositions
US8937096B2 (en)	2005-12-19	2015-01-20	Janssen Pharmaceutica Nv	Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8492431B2 (en)	2005-12-19	2013-07-23	Janssen Pharmaceutica, N.V.	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8691867B2 (en)	2005-12-19	2014-04-08	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en)	2005-12-19	2013-07-30	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en)	2005-12-19	2014-05-06	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070191461A1 (en) *	2006-02-15	2007-08-16	Smith-Swintosky Virginia L	Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
AU2007253814A1 (en)	2006-05-19	2007-11-29	Janssen Pharmaceutica N.V.	Co-therapy for the treatment of epilepsy
EP2124556B1 (en)	2006-10-09	2014-09-03	Charleston Laboratories, Inc.	Pharmaceutical compositions
CN101687788A (zh) *	2006-10-19	2010-03-31	奥斯拜客斯制药有限公司	取代的吲哚
US20080275030A1 (en) *	2007-01-19	2008-11-06	Sveinbjorn Gizurarson	Methods and Compositions for the Delivery of a Therapeutic Agent
GB2448183A (en) *	2007-04-05	2008-10-08	Optinose As	Nasal powder delivery device
CA2905541C (en)	2008-01-09	2020-02-11	Charleston Laboratories, Inc.	Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US20090252791A1 (en) *	2008-04-02	2009-10-08	Venkata Nookaraju Sreedharala	Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
BRPI0912038A2 (pt)	2008-05-27	2017-06-20	Biota Scient Management Pty Ltd	composto, mistura, composição farmacêutica, uso do composto, e, métodos para tratar e evitar uma infecção por picornavírus, e para formar o composto
US8618157B2 (en) *	2008-06-20	2013-12-31	Alphapharm Pty. Ltd.	Pharmaceutical formulation
US8809385B2 (en)	2008-06-23	2014-08-19	Janssen Pharmaceutica Nv	Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
WO2010005507A1 (en) *	2008-06-30	2010-01-14	Afgin Pharma, Llc	Topical regional neuro-affective therapy
US8815939B2 (en)	2008-07-22	2014-08-26	Janssen Pharmaceutica Nv	Substituted sulfamide derivatives
EP3311667A1 (en)	2009-07-08	2018-04-25	Charleston Laboratories, Inc.	Pharmaceutical compositions
US11337962B2 (en)	2009-09-25	2022-05-24	Upsher-Smith Laboratories, Llc	Formulations comprising triptan compounds
US9211282B2 (en) *	2009-09-25	2015-12-15	Dr. Reddy's Laboratories Ltd.	Formulations comprising triptan compounds
AU2016226267A1 (en)	2015-03-02	2017-09-28	Afgin Pharma, Llc	Topical regional neuro-affective therapy with cannabinoids
US10383816B2 (en)	2015-03-02	2019-08-20	Afgin Pharma, Llc	Topical regional neuro-affective therapy with cannabinoid combination products
EP3294339B1 (en)	2015-05-15	2020-12-02	The Regents Of The University Of Michigan	Methods and compositions for the treatment of arthritis
WO2017152130A1 (en)	2016-03-04	2017-09-08	Charleston Laboratories, Inc.	Pharmaceutical compositions
US20180049994A1 (en)	2016-08-16	2018-02-22	Afgin Pharma, Llc	Topical regional neuro-affective therapy with caryophyllene
EP3706744B1 (en)	2017-11-07	2022-08-17	The Regents of The University of Michigan	Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
WO2020049523A1 (en)	2018-09-07	2020-03-12	Upsher-Smith Laboratories, Llc	Methods of treating migraine
US11364225B2 (en) *	2019-08-21	2022-06-21	Bn Intellectual Properties, Inc.	Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
MX2022010407A (es) *	2020-02-27	2022-11-07	Biohaven Pharm Holding Co Ltd	Forma de dosis oral de rápida dispersión de rimegepant.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2162522B (en) *	1984-08-01	1988-02-24	Glaxo Group Ltd	An indole derivative
GB8615599D0 (en) *	1986-06-26	1986-07-30	Glaxo Group Ltd	Chemical compounds
GB8928208D0 (en) *	1989-12-13	1990-02-14	Glaxo Group Ltd	Medicaments

1990
- 1990-12-12 GB GB909026998A patent/GB9026998D0/en active Pending
1991
- 1991-12-10 YU YU191491A patent/YU48926B/sh unknown
- 1991-12-10 JP JP4501645A patent/JP2994037B2/ja not_active Expired - Lifetime
- 1991-12-10 RU RU93053493A patent/RU2108328C1/ru not_active IP Right Cessation
- 1991-12-10 CA CA002098302A patent/CA2098302C/en not_active Expired - Lifetime
- 1991-12-10 KR KR1019930701760A patent/KR100211479B1/ko not_active Expired - Fee Related
- 1991-12-10 AU AU90720/91A patent/AU650706B2/en not_active Expired
- 1991-12-10 WO PCT/EP1991/002362 patent/WO1992010477A1/en not_active Ceased
- 1991-12-10 CZ CS931140A patent/CZ281931B6/cs not_active IP Right Cessation
- 1991-12-11 TW TW081105493A patent/TW300886B/zh active
- 1991-12-11 IS IS3790A patent/IS1706B/is unknown
- 1991-12-11 CN CN91107596A patent/CN1030890C/zh not_active Expired - Fee Related
- 1991-12-11 NZ NZ240942A patent/NZ240942A/en not_active IP Right Cessation
- 1991-12-11 AP APAP/P/1991/000339A patent/AP230A/en active
- 1991-12-11 NL NL9102071A patent/NL9102071A/nl not_active Application Discontinuation
- 1991-12-11 TW TW080109719A patent/TW205035B/zh not_active IP Right Cessation
- 1991-12-11 MX MX9102501A patent/MX9102501A/es unknown
- 1991-12-11 EG EG75391A patent/EG20219A/xx active
- 1991-12-11 IE IE431791A patent/IE62894B1/en not_active IP Right Cessation
- 1991-12-11 IL IL10033091A patent/IL100330A/en not_active IP Right Cessation
- 1991-12-11 ZA ZA919750A patent/ZA919750B/xx unknown
- 1991-12-11 FR FR919115359A patent/FR2670487B1/fr not_active Expired - Lifetime
- 1991-12-11 PT PT99757A patent/PT99757B/pt not_active IP Right Cessation
- 1991-12-11 IT ITRM910922A patent/IT1252868B/it active IP Right Grant
- 1991-12-11 BE BE9101129A patent/BE1005085A3/fr not_active IP Right Cessation
- 1991-12-11 CH CH3647/91A patent/CH684192A5/fr not_active IP Right Cessation
- 1991-12-11 MY MYPI91002297A patent/MY109265A/en unknown
- 1991-12-11 GB GB9126297A patent/GB2251614B/en not_active Revoked
- 1991-12-12 ES ES91311583T patent/ES2069836T3/es not_active Expired - Lifetime
- 1991-12-12 DE DE69108200T patent/DE69108200T2/de not_active Expired - Lifetime
- 1991-12-12 AT AT91311583T patent/ATE119881T1/de not_active IP Right Cessation
- 1991-12-12 EP EP91311583A patent/EP0490689B1/en not_active Expired - Lifetime
- 1991-12-12 DK DK91311583.8T patent/DK0490689T3/da active
1995
- 1995-02-20 CN CN95100529A patent/CN1050831C/zh not_active Expired - Fee Related
- 1995-03-16 GR GR940403944T patent/GR3015430T3/el unknown
- 1995-06-02 US US08/460,791 patent/US5554639A/en not_active Expired - Lifetime
- 1995-06-23 HU HU95P/P00422P patent/HU211937A9/hu unknown
1996
- 1996-05-21 US US08/651,961 patent/US5705520A/en not_active Expired - Lifetime
1997
- 1997-06-19 HK HK82697A patent/HK82697A/en not_active IP Right Cessation
- 1997-12-05 CY CY200597A patent/CY2005A/xx unknown

Also Published As

Publication number	Publication date
KR100211479B1 (ko)	1999-08-02
CZ281931B6 (cs)	1997-04-16
HK82697A (en)	1997-06-27
EP0490689B1 (en)	1995-03-15
DE69108200D1 (de)	1995-04-20
IL100330A (en)	1996-06-18
AU9072091A (en)	1992-07-08
CA2098302A1 (en)	1992-06-13
MY109265A (en)	1996-12-31
CZ114093A3 (en)	1994-02-16
GR3015430T3 (en)	1995-06-30
GB9026998D0 (en)	1991-01-30
MX9102501A (es)	1992-09-01
DK0490689T3 (da)	1995-05-22
IT1252868B (it)	1995-06-28
ITRM910922A0 (it)	1991-12-11
DE69108200T2 (de)	1995-07-20
CY2005A (en)	1997-12-05
CA2098302C (en)	2001-10-16
AP230A (en)	1993-01-27
GB2251614B (en)	1994-12-14
FR2670487A1 (fr)	1992-06-19
IE62894B1 (en)	1995-03-08
CH684192A5 (fr)	1994-07-29
JP2994037B2 (ja)	1999-12-27
YU191491A (sh)	1994-04-05
BE1005085A3 (fr)	1993-04-13
NZ240942A (en)	1994-03-25
EP0490689A1 (en)	1992-06-17
TW205035B (is)	1993-05-01
AP9100339A0 (en)	1992-01-31
PT99757A (pt)	1992-12-31
TW300886B (is)	1997-03-21
ITRM910922A1 (it)	1993-06-11
ES2069836T3 (es)	1995-05-16
US5705520A (en)	1998-01-06
EG20219A (en)	1997-11-30
PT99757B (pt)	1999-05-31
HU211937A9 (en)	1996-01-29
IS1706B (is)	1998-12-10
RU2108328C1 (ru)	1998-04-10
YU48926B (sh)	2002-12-10
IE914317A1 (en)	1992-06-17
CN1063099A (zh)	1992-07-29
US5554639A (en)	1996-09-10
ZA919750B (en)	1992-10-28
WO1992010477A1 (en)	1992-06-25
IL100330A0 (en)	1992-09-06
JPH06503560A (ja)	1994-04-21
FR2670487B1 (fr)	1993-08-20
AU650706B2 (en)	1994-06-30
NL9102071A (nl)	1992-07-01
ATE119881T1 (de)	1995-04-15
CN1128259A (zh)	1996-08-07
CN1050831C (zh)	2000-03-29
GB2251614A (en)	1992-07-15
CN1030890C (zh)	1996-02-07
GB9126297D0 (en)	1992-02-12

Publication	Publication Date	Title
IS1706B (is)	1998-12-10	Hliðstæð aðferð til framleiðslu á 3-[-2-(dímeltýlamínó)etýl]-N-metýl-1H-indól-5-metansúlfónamíð súlfat salti
FI914174A7 (fi)	1992-03-06	Menetelmä piperidyylialkyyliamiinien valmistamiseksi
DK36491D0 (da)	1991-03-01	Praeparat til behandling af erektiv dysfunktion
NO910421D0 (no)	1991-02-04	Fremgangsmaate for fremstilling av en spiselig emulsjon.
DK0485436T3 (da)	1995-04-10	Fremgangsmåde til fremstilling af et næringsmiddel med reduceret fedtstofindhold
FI905124A0 (fi)	1990-10-17	Menetelmä pyrimidiinien valmistamiseksi
FI945441A7 (fi)	1994-11-18	Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmi stamiseksi
IS1667B (is)	1997-11-14	Hliðstæð aðferð við framleiðslu á meðferðarvirkumbis-aza-bísýklískum efnasamböndum
NO891109L (no)	1989-09-18	Badesaltblanding.
FI95036B (fi)	1995-08-31	Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI911713L (fi)	1991-10-12	Menetelmä stereokemiallisesti puhtaiden ergoliini-8-karboksiamidien valmistamiseksi
DK0721453T3 (da)	2003-03-17	Fremgangsmåde til fremstilling af N-methyl-3-(1-methyl-4-piperidinyl)-14-indol-5-ethansulfonamid
FI890186A7 (fi)	1989-07-16	Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
TR26125A (tr)	1995-02-15	Modifiye edilmis kaucuktan stiren recineler hazirlanmasi icin yöntem
FI961054L (fi)	1996-03-07	Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
FI890185A7 (fi)	1989-07-16	Menetelmä 1-alkyyli-5-nitroimidatsolien valmistamiseksi
EE03027B1 (et)	1997-08-15	Meetod 8-klorokinolooni derivaatide valmistamiseks
FI933755A7 (fi)	1993-08-26	Menetelmä trans-piperidiini-2,5-dikarboksylaattien valmistamiseksi
FI910847A0 (fi)	1991-02-21	Menetelmä kolestipolihydrokloridin valmistamiseksi
FI913464A7 (fi)	1992-01-21	Menetelmä 1-hydroksimetyylipyratsolien valmistamiseksi
FI890188A7 (fi)	1989-07-16	Menetelmä 1-hydroksialkyyli-2-metyyli-5-nitroimidatsolien valmistamiseksi
FI904570A7 (fi)	1991-03-20	Menetelmä uusien alkanofenonien valmistamiseksi I
FI923866A7 (fi)	1992-08-28	Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
FI892144A7 (fi)	1989-11-06	Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
FI940338L (fi)	1994-01-24	Menetelmä 13alfa-sinnamoyylibakkatiini III:n tai -10-desasetyylibakkatiini III:n valmistamiseksi